slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
25,45 TWD | +0,20% | +2,00% | -14,45% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Antibody New Drug
100,0
%
| 30 | 100,0 % | 3 | 100,0 % | -91,55% |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Japan
63,3
%
| 19 | 64,1 % | 2 | 63,3 % | -91,65% |
Taiwan
36,7
%
| 0 | 1,6 % | 1 | 36,7 % | +99,36% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mei Chun Yang
CEO | Chief Executive Officer | - | 01-01-07 |
Tong Hsuan Chang
FOU | Founder | - | 01-02-01 |
Dih Fen Wu
DFI | Director of Finance/CFO | - | 01-01-10 |
Yao Hua Lue
IRC | Investor Relations Contact | - | 12-11-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kao Chung Tsai
BRD | Director/Board Member | 62 | - |
Tong Hsuan Chang
FOU | Founder | - | 01-02-01 |
Ling-Chun Tsai
BRD | Director/Board Member | - | 25-05-12 |
Hsiu E. Su
BRD | Director/Board Member | - | - |
Tseng-Fu Chen
BRD | Director/Board Member | - | 25-05-12 |
Cai Qing Hong
BRD | Director/Board Member | - | - |
Zong Zheng Wu
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 108 640 100 | 89 098 133 ( 82,01 %) | 0 | 82,01 % |
Bedrijfsgegevens
GlycoNex, Inc.
8th Floor, Section 1 No. 97 Xintai 5th Road
221 75, New Taipei
+
http://www.glyconex.com.twSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,45% | 85,51 mln. | |
+39,78% | 54,04 mld. | |
+43,57% | 41,96 mld. | |
-1,11% | 41,92 mld. | |
-7,59% | 28,35 mld. | |
+12,78% | 26,35 mld. | |
-22,09% | 19 mld. | |
+7,75% | 13 mld. | |
+28,09% | 12,28 mld. | |
+25,10% | 12,19 mld. |
- Beurs
- Aandelen
- Koers 4168
- Onderneming GlycoNex Incorporation